Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 27, 2015 08:00 ET | Source: StemCells, Inc.

StemCells, Inc. to Participate at the Inaugural World Medical Innovation Forum

NEWARK, Calif., April 27, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Martin McGlynn, CEO of StemCells, Inc., will participate on a panel moderated by Alice Park,...
April 24, 2015 09:25 ET | Source: StemCells, Inc.

StemCells, Inc. Announces Pricing of Public Offering to Raise $25 Million

NEWARK, Calif., April 24, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced the pricing of an underwritten public offering of common stock and warrants with a public offering...
April 23, 2015 16:14 ET | Source: StemCells, Inc.

StemCells, Inc. Announces Proposed Public Offering of Common Stock and Warrants

NEWARK, Calif., April 23, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that it intends to offer and sell common stock and warrants, subject to market and other conditions, in...
April 16, 2015 08:00 ET | Source: StemCells, Inc.

StemCells, Inc. Completes Enrollment of First Cohort in Phase II Pathway Study for Cervical Spinal Cord Injury

NEWARK, Calif., April 16, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for treating diseases of the central nervous...
April 07, 2015 08:00 ET | Source: StemCells, Inc.

StemCells, Inc. to Participate at the 14th Annual Needham Healthcare Conference

NEWARK, Calif., April 7, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Martin McGlynn, CEO of StemCells, Inc., will make a presentation on the Company's programs and...
March 24, 2015 10:34 ET | Source: StemCells, Inc.

StemCells, Inc. Appoints Ian Massey as President and Chief Operating Officer

NEWARK, Calif., March 24, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system,...
March 16, 2015 16:05 ET | Source: StemCells, Inc.

StemCells, Inc. Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Business Update

NEWARK, Calif., March 16, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics for diseases of the central...
March 10, 2015 08:00 ET | Source: StemCells, Inc.

StemCells, Inc. to Participate at the Wall Street Analyst Forum 25th Annual Institutional Investor Conference

NEWARK, Calif., March 10, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Management will make a presentation on the Company's programs and operations at the Wall Street...
March 09, 2015 08:00 ET | Source: StemCells, Inc.

StemCells, Inc. Announces Webcast to Discuss Fourth Quarter and Full Year 2014 Financial Results

NEWARK, Calif., March 9, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
February 05, 2015 08:00 ET | Source: StemCells, Inc.

Safety and Preliminary Efficacy of Human Neural Stem Cells in StemCells, Inc.'s Dry AMD Study to be Presented at Ophthalmology Conference

NEWARK, Calif., Feb. 5, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system,...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right